Emami logo

Emami

EMAMILTD NSE

Key Fundamentals

SmallcapPersonal CareConsumer Goods
Market Cap
₹16,037 Cr
Volatility
Moderate
P/E Ratio
21.21
EBITDA
₹1,049 Cr
Return on Equity
26.53%
Debt to Equity
0.06
Book Value
₹66.99
EPS
₹17.04
52W High
₹614
52W Low
₹361.15

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

4
  • Company is almost debt free.
  • Company has a good return on equity (ROE) track record: 3 Years ROE 28.5%
  • Company has been maintaining a healthy dividend payout of 52.9%
  • Debtor days have improved from 42.3 to 33.2 days.

Weaknesses

2
  • The company has delivered a poor sales growth of 5.58% over past five years.
  • Tax rate seems low

Growth Rate

Revenue Growth
-0.33% lower than 3Y
Net Income Growth
-3.41% lower than 3Y
Cash Flow Change
-10.64% lower than 3Y
ROE
-10.97% lower than 3Y
ROCE
-12.81% lower than 3Y
EBITDA Margin (Avg.)
-3.76% lower than 3Y

AI Analysis — Bull vs Bear

Anthropic anthropic claude-opus-4.6 2d ago
AI opinion · based on fundamentals
Risk medium

Emami Ltd is a nearly debt-free FMCG company with a market cap of ₹16,037 Cr, trading at a PE of 21.6x with a consistent ROE averaging 28% over 3 years. However, the company faces sluggish top-line growth at a 5-year sales CAGR of just 6% and a sharp stock price decline of -38% over the past year, reflecting investor concerns about growth momentum.

Bull Case 8
  • Near debt-free balance sheet provides financial flexibility and resilience during economic downturns, reducing interest cost burden on profitability.
  • Strong return on equity track record with 3-year ROE of 28% and 5-year ROE of 31%, indicating efficient capital allocation relative to FMCG peers.
  • Healthy dividend payout ratio of 52.9% combined with a dividend yield of 2.7%, offering meaningful income return to shareholders.
  • Improvement in debtor days from 42.3 to 33.2 days signals better working capital management and faster cash conversion.
  • Compounded profit growth of 11% over 5 years outpaces 6% sales growth over the same period, reflecting margin expansion and cost discipline.
  • PE ratio of 21.6x is relatively modest for an established FMCG franchise, compared to larger consumer goods peers that often trade at 40-60x earnings.
  • 10-year ROE of 26% demonstrates long-term consistency in generating returns on shareholder equity across business cycles.
  • Price-to-book ratio of 5.54x, while not cheap in absolute terms, is underpinned by the high ROE profile and asset-light business model.
Bear Case 7
  • Poor sales growth of just 5.58% compounded over the past 5 years suggests limited volume and pricing power in core categories.
  • Stock price has declined -38% over the past 1 year and shows negative CAGR across all time horizons: -13% over 3 years, -9% over 5 years, and -5% over 10 years.
  • TTM profit growth has turned negative at -7%, indicating recent earnings deterioration despite the longer-term profit growth trend.
  • TTM sales growth of only 3% signals continued top-line weakness and potential market share pressures in key product segments.
  • Apparently low effective tax rate raises questions about sustainability of earnings if tax benefits expire or regulatory changes occur.
  • 10-year compounded profit growth of just 6% aligned closely with sales growth of 5%, suggesting limited structural margin improvement over longer horizons.
  • Market cap of ₹16,037 Cr places Emami in the mid-cap FMCG space, making it more vulnerable to competitive pressures from larger, better-resourced peers.

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

Anthropic anthropic claude-opus-4.6 2h ago
Headwinds 1
  • EBITDA growth lags revenue Aug 25

    EBITDA grew only 6% YoY in Q1FY27 versus 15% revenue growth, indicating input cost pressures are squeezing margins.

Positives 2
  • Strong Q1 revenue, domestic surge Aug 25

    Q1FY27 revenue rose 15% YoY to ₹1,039 crore, powered by 20% domestic growth. Company declared ₹436.5 crore in FY26 dividends.

  • 43rd AGM, directors reappointed Aug 25

    Emami held its 43rd AGM on Aug 25, approving FY26 financial statements and reappointing three retiring directors, ensuring board continuity.

Neutral 2
  • Promoters pledge and release shares Sep 5

    Diwakar Finvest and Suraj Finvest disclosed creation and release of pledges on Emami shares between Aug 28 and Sep 2, 2026.

  • Company Secretary resigns Aug 29

    Ravi Varma's resignation as Company Secretary and Compliance Officer was accepted, effective Aug 31, 2026. He also ceases to be Nodal Officer.

TL;DR: Emami delivered a solid Q1FY27 topline with 15% revenue growth and robust 20% domestic demand, complemented by a generous ₹436.5 crore dividend payout. However, EBITDA growing at just 6% signals margin headwinds from rising input costs. Corporate actions like share pledges and a CS departure are routine and non-material. The revenue momentum is encouraging, but margin trajectory in coming quarters will be key to watch as cost pressures persist.

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
826
865
996
891
906
891
1,049
963
904
799
1,152
925
1,039
Expenses
636
632
682
682
692
645
715
744
692
622
768
739
815
Operating Profit
190
233
314
209
214
246
334
219
212
177
384
186
225
OPM %
23%
27%
32%
24%
24%
28%
32%
23%
23%
22%
33%
20%
22%
Other Income
8
11
11
11
10
22
15
21
22
21
9
23
18
Interest
2
2
3
3
2
2
2
3
2
3
3
3
6
Depreciation
46
46
46
48
44
45
46
44
44
45
45
42
43
PBT
150
196
276
169
178
220
301
194
187
150
345
164
195
Tax %
9%
8%
6%
13%
16%
4%
7%
16%
12%
1%
7%
13%
29%
Net Profit
137
180
261
147
151
211
279
162
164
148
319
143
139
EPS in Rs
3.14
4.09
5.92
3.41
3.5
4.87
6.39
3.72
3.76
3.4
7.32
3.28
3.15
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
2,076
2,358
2,488
2,531
2,695
2,655
2,881
3,192
3,406
3,578
3,809
3,780
3,915
Expenses
1,536
1,670
1,729
1,812
1,970
1,970
2,000
2,254
2,550
2,632
2,796
2,820
2,943
Operating Profit
541
688
759
719
725
685
880
938
855
946
1,014
960
972
OPM %
26%
29%
31%
28%
27%
26%
31%
29%
25%
26%
27%
25%
25%
Other Income
91
44
31
19
25
46
69
90
69
41
68
75
72
Interest
5
54
58
34
21
21
13
5
7
10
9
11
14
Depreciation
34
255
309
311
325
336
367
335
247
186
178
177
176
PBT
592
423
424
393
403
374
569
688
670
791
894
846
854
Tax %
18%
14%
20%
22%
25%
19%
20%
-22%
6%
8%
10%
8%
—
Net Profit
485
363
340
306
303
302
455
837
627
724
803
775
750
EPS in Rs
10.7
8
7.5
6.77
6.68
6.67
10.23
19.02
14.5
16.58
18.48
17.76
17.15
Div. Payout %
33%
44%
47%
52%
60%
60%
78%
42%
55%
48%
54%
56%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
23
23
23
23
45
45
44
44
44
44
44
44
Reserves
1,208
1,589
1,732
1,991
2,031
1,778
1,718
2,032
2,259
2,403
2,651
2,880
Borrowings
36
671
473
326
110
210
101
282
91
94
90
162
Other Liabilities
410
409
376
458
633
644
656
692
703
728
741
745
Total Liabilities
1,676
2,692
2,603
2,798
2,819
2,678
2,520
3,050
3,096
3,269
3,525
3,831
Fixed Assets
453
1,918
1,994
1,802
1,680
1,459
1,132
1,344
1,245
1,114
984
886
CWIP
29
67
22
30
36
8
6
3
6
8
15
1
Investments
501
104
128
314
187
156
255
303
293
442
676
834
Other Assets
693
604
460
652
915
1,055
1,126
1,400
1,551
1,706
1,850
2,108
Total Assets
1,676
2,692
2,603
2,798
2,819
2,678
2,520
3,050
3,096
3,269
3,525
3,831
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
534
562
730
588
554
531
922
644
749
779
896
801
Investing
-237
-1,313
-306
-276
-26
-231
-224
-234
-122
-210
-345
-174
Financing
-215
502
-496
-324
-428
-405
-688
-402
-608
-563
-500
-554
Net Cash Flow
82
-249
-72
-12
100
-106
9
8
19
6
52
72
Free Cash Flow
426
430
448
465
421
383
890
164
719
750
852
770
CFO/OP
116
96
105
93
89
89
115
84
101
98
107
101
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
18
20
14
22
29
42
29
37
44
50
43
33
Inventory Days
59
68
83
87
88
102
118
121
100
102
94
128
Days Payable
90
112
85
109
115
135
138
138
124
143
133
153
Cash Conversion Cycle
-13
-24
12
1
2
9
10
19
20
9
4
8
Working Capital Days
-16
-54
-62
-32
-6
7
-3
0
28
30
25
21
ROCE %
61%
30%
23%
22%
19%
18%
29%
31%
28%
32%
32%
28%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Emami insights

73 extracted metrics + investor summaries across FY11–FY27.

Log in — free

Shareholding Pattern

Others4.51%Promot.54.84%Public5.76%FIIs7.87%DIIs27.01%As ofJun 2026
16.23% of promoter holding pledged as of Jun 2026

Documents

Frequently Asked Questions about Emami

What does Emami Ltd do?
Emami is engaged in manufacturing & marketing of personal care & healthcare products with an enviable portfolio of household brand names such as BoroPlus, Navratna, Fair and Handsome, Zandu Balm, Kesh King, Zandu Pancharishta, Mentho Plus Balm and others.(Source : 201903 Annual Report Page No: 193)
Where is Emami Ltd (EMAMILTD) listed?
Emami Ltd trades as EMAMILTD on the NSE and under code 531162 on the BSE.
Which sector does Emami Ltd belong to?
Emami Ltd is classified under the Consumer Goods sector, in the Personal Care industry.
What is the market capitalisation of Emami Ltd?
Emami Ltd has a market capitalisation of ₹16,037 Cr, which places it in the Mid Cap band.
What is the PE ratio of Emami Ltd?
Emami Ltd trades at a PE ratio of 21.21, on earnings per share of ₹17.04, against a book value of ₹66.99 per share.
What is the 52-week high and low of Emami Ltd?
Over the last 52 weeks Emami Ltd has traded between ₹361.15 and ₹614.
Does Emami Ltd pay dividends?
Emami Ltd has a dividend yield of 2.70%.
What is the Return on Equity (ROE) of Emami Ltd?
Emami Ltd reported a return on equity of 26.53%. Its debt-to-equity ratio is 0.06.

Company Information

Emami is engaged in manufacturing & marketing of personal care & healthcare products with an enviable portfolio of household brand names such as BoroPlus, Navratna, Fair and Handsome, Zandu Balm, Kesh King, Zandu Pancharishta, Mentho Plus Balm and others.(Source : 201903 Annual Report Page No: 193)

Website emamiltd.in
CEO Mr. Radhe Shyam Goenka B.Com., L.L.B., M.Com. LLB
Employees 3,217
Listed 2006-08-03
Face Value ₹ 1
Issued Size 43,65,00,000

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/EMAMILTD.md for Emami Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Consumer Goods → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List